Release Date: 28/02/19 15:59 Summary: December 2018 Half Year Report and Accounts Price Sensitive: Yes Download Document 876.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%